• Synthetic Genomics, Advaxis Launch Venture to Produce Synthetic DNA for Immunotherapy Clinical Trials
  • S-1 and Platinol Combo Shows Promise Against Cervical Cancer, Phase 3 Trial Indicates
  • Opdivo Showing Early Promise in Advanced Cervical Cancer Patients Enrolled in Phase 1/2 Trial
  • Experimental New Device May Allow for Easier Cervical Cancer Screening
  • Patients Being Recruited for Phase 2 Trial of Keytruda and Chemoradiation in Cervical Cancer
  • New Study to Assess ADXS-DUAL, Opdivo Immunotherapy Combo in Metastatic Cervical Cancer
  • Keytruda Shows Promise in People with Advanced Disease, Early Phase 2 Trial Results Show
  • Chemotherapy Plus P53 Gene Therapy May Help Treat Locally Advanced Cervical Cancer
  • Cervical Cancer Screening Device Mía, by Mel-Mont Medical, Allows HPV Sampling at Home
  • Cervical Cancer Patient Achieves Long-lasting Response to AXAL in Clinical Trial
  • 2 Doses of HPV Vaccine Protect Against Genital Warts, Study Finds, But Impact on Cancer Unknown
  • New Testing that Uses HPV DNA Could Help Identify Potentially Cancerous Cervical Lesions